Chinese AceCGT bags distribution deal with Belgian MDxHealth for prostate cancer assay in Hong Kong and Macao

MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong and Macao, Special Administrative Regions of the People`s Republic of China.

MDxHealth on Monday said that AceCGT Group will be the exclusive distributor within the Hong Kong and Macao Special Administrative Regions. Patient samples will be sent to MDxHealth`s state-of-the-art ISO certified clinical diagnostic laboratory in Nijmegen, The Netherlands for analysis.

“We are delighted to announce our collaboration with AceCGT Group for the distribution of SelectMDx within the People`s Republic of China. We believe that SelectMDx perfectly complements AceCGT Group`s cutting edge molecular diagnostic test menu,” said Dr. Jan Groen, CEO of MDxHealth. “With their highly qualified and experienced team of laboratory scientists, clinical researchers and a dedicated commercial team, AceCGT Group is an ideal partner to help us raise awareness and expand access to SelectMDx throughout Hong Kong and Macao.”